MYC and neoplasm: Cases with MYC pathogenic mutations were significantly associated with higher MYC protein expression as assessed by immunohistochemistry and quantitative imaging analysis.  This could potentially explain in part the variability (20–100%) of MYC protein expression in tumour cells of MYC translocation positive DLBCL [50].